First, this is the first report of TSH-PitNET combined with breast cancer; second, the breast cancer specimen was positive for SSTR2 and IGF-1R immunoreactivity; third, the breast cancer showed a complete response after treatment with SSA and chemotherapy. This evidence concerns the gene IGF1R and breast cancer.